<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The inflammatory factor C-reactive protein (CRP) and the fibrinolytic variables fibrinogen and plasminogen activator-1 (PAI-1) are associated with long-term <z:e sem="disease" ids="C1301700" disease_type="Disease or Syndrome" abbrv="">cardiovascular morbidity</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>To determine the contribution of body <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> (BMI), insulin sensitivity (homeostasis model assessment of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> [HOMA-IR], and glycemia (HbA(1c) [A1C]) to the levels of these inflammatory and fibrinolytic variables in recently diagnosed (&lt;or=3 years), drug-naive, type 2 diabetic subjects (fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> &lt;or=10 mmol/l), we examined a representative subgroup (n = 921) of the U.S. cohort in ADOPT (A <z:mp ids='MP_0002055'>Diabetes</z:mp> Outcome Progression Trial) </plain></SENT>
<SENT sid="2" pm="."><plain>The relationship between levels of CRP, fibrinogen, PAI-1 antigen and PAI-1 activity, and baseline variables including National Cholesterol Education Program Adult Treatment Panel III <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> phenotype were explored </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> four factors increased significantly with increasing numbers of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> components (P = 0.0136 to P &lt; 0.0001) </plain></SENT>
<SENT sid="4" pm="."><plain>BMI (P &lt; 0.0001) and HOMA-IR (P &lt; 0.0001) but not A1C (P = 0.65) increased with increasing numbers of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> components </plain></SENT>
<SENT sid="5" pm="."><plain>Adjustment of CRP levels for BMI eliminated the association between CRP and the number of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> components, while adjusting for HOMA-IR did not (P = 0.0028) </plain></SENT>
<SENT sid="6" pm="."><plain>The relationships of PAI-1 antigen and PAI-1 activity with the number of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> components were maintained after adjusting for BMI (P = 0.0002 and P = &lt;0.0001, respectively) or HOMA-IR (P = 0.0008 and P = &lt;0.0001, respectively), whereas that with fibrinogen was eliminated after adjusting for BMI but not after adjusting for HOMA-IR (P = 0.013) </plain></SENT>
<SENT sid="7" pm="."><plain>Adjustment for A1C had no effect on any of the relationships between the inflammatory and fibrinolytic factors and the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that in recently diagnosed, drug-naive type 2 diabetic subjects, markers of <z:mp ids='MP_0001845'>inflammation</z:mp> and fibrinolysis are strongly related to the number of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> components </plain></SENT>
<SENT sid="9" pm="."><plain>Further, for CRP and fibrinogen this relationship is determined by body <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> and not by insulin sensitivity or <z:chebi fb="105" ids="17234">glucose</z:chebi> control </plain></SENT>
</text></document>